EARLY DISCONTINUATION OF ANTIBIOTICS BASED ON PROCALCITONIN LEVEL IN COVID-19 PNEUMONIA
Gespeichert in:
Veröffentlicht in: | Chest 2021-10, Vol.160 (4), p.A1099-A1099 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | A1099 |
---|---|
container_issue | 4 |
container_start_page | A1099 |
container_title | Chest |
container_volume | 160 |
creator | ROY, ARCHANA NAGA YARRARAPU, SIVA NAZARENO, MARK SANGHAVI, DEVANG |
description | |
doi_str_mv | 10.1016/j.chest.2021.07.1013 |
format | Article |
fullrecord | <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8503101</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0012369221024648</els_id><sourcerecordid>S0012369221024648</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2013-f68e53ffe72a46cf64cc733dae383f6ae9075d3c98e36c6fec856599e5d012283</originalsourceid><addsrcrecordid>eNp9UMFOg0AQ3RhNrNU_8LA_AO6ysMDFhFKqmyDbtLTG0waXwdK0pYHaxL93sUbjxdPMvJd5M-8hdEuJTQnld2tbr6A72A5xqE38HmRnaEBDRi3muewcDQihjsV46Fyiq65bEzPTkA_QcxLN0hc8FvNYZrnIFlEuZIblBEdmHAmZi3iOR9E8GWODT2cyjtJY5DITGU6TZZJi08RyKcYWDfE0SxZPhouu0UVVbDq4-a5DtJgkefxopfJBGAlLO-ZJq-IBeKyqwHcKl-uKu1r7jJUFsIBVvICQ-F7JdBgA45pXoAOPe2EIXmkMOQEbovuT7v79dQulht2hLTZq39bbov1QTVGrv8yuXqm35qgCj7A-pyFyTwK6bbquhepnlxLVp6vW6itd1aeriN-D7PcuGHPHGlrV6Rp2Gsq6BX1QZVP_L_AJTIl-NA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>EARLY DISCONTINUATION OF ANTIBIOTICS BASED ON PROCALCITONIN LEVEL IN COVID-19 PNEUMONIA</title><source>Alma/SFX Local Collection</source><creator>ROY, ARCHANA ; NAGA YARRARAPU, SIVA ; NAZARENO, MARK ; SANGHAVI, DEVANG</creator><creatorcontrib>ROY, ARCHANA ; NAGA YARRARAPU, SIVA ; NAZARENO, MARK ; SANGHAVI, DEVANG</creatorcontrib><identifier>ISSN: 0012-3692</identifier><identifier>EISSN: 1931-3543</identifier><identifier>DOI: 10.1016/j.chest.2021.07.1013</identifier><language>eng</language><publisher>Elsevier Inc</publisher><subject>Critical Care</subject><ispartof>Chest, 2021-10, Vol.160 (4), p.A1099-A1099</ispartof><rights>2021 American College of Chest Physicians</rights><rights>Copyright © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. 2021 American College of Chest Physicians</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids></links><search><creatorcontrib>ROY, ARCHANA</creatorcontrib><creatorcontrib>NAGA YARRARAPU, SIVA</creatorcontrib><creatorcontrib>NAZARENO, MARK</creatorcontrib><creatorcontrib>SANGHAVI, DEVANG</creatorcontrib><title>EARLY DISCONTINUATION OF ANTIBIOTICS BASED ON PROCALCITONIN LEVEL IN COVID-19 PNEUMONIA</title><title>Chest</title><subject>Critical Care</subject><issn>0012-3692</issn><issn>1931-3543</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9UMFOg0AQ3RhNrNU_8LA_AO6ysMDFhFKqmyDbtLTG0waXwdK0pYHaxL93sUbjxdPMvJd5M-8hdEuJTQnld2tbr6A72A5xqE38HmRnaEBDRi3muewcDQihjsV46Fyiq65bEzPTkA_QcxLN0hc8FvNYZrnIFlEuZIblBEdmHAmZi3iOR9E8GWODT2cyjtJY5DITGU6TZZJi08RyKcYWDfE0SxZPhouu0UVVbDq4-a5DtJgkefxopfJBGAlLO-ZJq-IBeKyqwHcKl-uKu1r7jJUFsIBVvICQ-F7JdBgA45pXoAOPe2EIXmkMOQEbovuT7v79dQulht2hLTZq39bbov1QTVGrv8yuXqm35qgCj7A-pyFyTwK6bbquhepnlxLVp6vW6itd1aeriN-D7PcuGHPHGlrV6Rp2Gsq6BX1QZVP_L_AJTIl-NA</recordid><startdate>202110</startdate><enddate>202110</enddate><creator>ROY, ARCHANA</creator><creator>NAGA YARRARAPU, SIVA</creator><creator>NAZARENO, MARK</creator><creator>SANGHAVI, DEVANG</creator><general>Elsevier Inc</general><general>American College of Chest Physicians. Published by Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>202110</creationdate><title>EARLY DISCONTINUATION OF ANTIBIOTICS BASED ON PROCALCITONIN LEVEL IN COVID-19 PNEUMONIA</title><author>ROY, ARCHANA ; NAGA YARRARAPU, SIVA ; NAZARENO, MARK ; SANGHAVI, DEVANG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2013-f68e53ffe72a46cf64cc733dae383f6ae9075d3c98e36c6fec856599e5d012283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Critical Care</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ROY, ARCHANA</creatorcontrib><creatorcontrib>NAGA YARRARAPU, SIVA</creatorcontrib><creatorcontrib>NAZARENO, MARK</creatorcontrib><creatorcontrib>SANGHAVI, DEVANG</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Chest</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ROY, ARCHANA</au><au>NAGA YARRARAPU, SIVA</au><au>NAZARENO, MARK</au><au>SANGHAVI, DEVANG</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>EARLY DISCONTINUATION OF ANTIBIOTICS BASED ON PROCALCITONIN LEVEL IN COVID-19 PNEUMONIA</atitle><jtitle>Chest</jtitle><date>2021-10</date><risdate>2021</risdate><volume>160</volume><issue>4</issue><spage>A1099</spage><epage>A1099</epage><pages>A1099-A1099</pages><issn>0012-3692</issn><eissn>1931-3543</eissn><pub>Elsevier Inc</pub><doi>10.1016/j.chest.2021.07.1013</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0012-3692 |
ispartof | Chest, 2021-10, Vol.160 (4), p.A1099-A1099 |
issn | 0012-3692 1931-3543 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8503101 |
source | Alma/SFX Local Collection |
subjects | Critical Care |
title | EARLY DISCONTINUATION OF ANTIBIOTICS BASED ON PROCALCITONIN LEVEL IN COVID-19 PNEUMONIA |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T05%3A44%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=EARLY%20DISCONTINUATION%20OF%20ANTIBIOTICS%20BASED%20ON%20PROCALCITONIN%20LEVEL%20IN%20COVID-19%20PNEUMONIA&rft.jtitle=Chest&rft.au=ROY,%20ARCHANA&rft.date=2021-10&rft.volume=160&rft.issue=4&rft.spage=A1099&rft.epage=A1099&rft.pages=A1099-A1099&rft.issn=0012-3692&rft.eissn=1931-3543&rft_id=info:doi/10.1016/j.chest.2021.07.1013&rft_dat=%3Celsevier_pubme%3ES0012369221024648%3C/elsevier_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0012369221024648&rfr_iscdi=true |